Mechanism of action: How Mounjaro and Ozempic work Both Mounjaro and Ozempic belong to a class of drugs called GLP-1 receptor agonists
However, patients must follow a comprehensive treatment plan that includes lifestyle modifications and regular monitoring to ensure the best possible results and minimize potential risks
It is a drug part of the glucagon-like-peptide 1 receptor antagonists, or GLP-1 receptor antagonist family, that when specifically used for treating weight loss, acts on GLP-1 receptors in the brain, on top of the liver, pancreas, and stomach
If you cannot find a Substance or Method listed, please verify its status with your Anti-Doping Organization for accurate and authoritative information
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial